Evolution of PET Fixation With FDG at the End of Antibiotic Treatment of Infective Endocarditis on Valvular Prosthesis
Recruiting now · Not applicable
Conditions studied: Prosthetic Valve Endocarditis
In brief
In patients with prosthetic valve endocarditis (PVE) and pathological valvular FDG uptake on the initial FDG-PET and not referred to valve replacement at the acute phase, the study will assess whether FDG-PET is able to identify those at increased risk of PVE relapse.
Key facts
- Study ID
- NCT05989152
- Run by
- Assistance Publique - Hôpitaux de Paris
- People needed
- 50
- Starts
- 2025-04-17
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2025-08-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Patient under legal protection, guardianship or curators;
- Pregnancy, breastfeeding;
- Patient not affiliated to a health insurance scheme or not a beneficiary of a social security scheme;
- Simultaneous participation in a study on FDG-PET;
- Absence of informed consent signed by the patient."
Where it is running
- Hôpital Bichat-Claude Bernard — Paris, France, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.